Johansson S, Lie B A, Todd J A, Pociot F, Nerup J, Cambon-Thomsen A, Kockum I, Akselsen H E, Thorsby E, Undlien D E
Institute of Immunology, Rikshospitalet, University Hospital, Norway.
Genes Immun. 2003 Jan;4(1):46-53. doi: 10.1038/sj.gene.6363917.
Susceptibility to, and protection against development of type 1 diabetes (T1D) are primarily associated with the highly polymorphic exon 2 sequences of the HLA class II genes: DQB1, DQA1 and DRB1. However, several studies have also suggested that additional genes in the HLA complex influence T1D risk, albeit to a lesser degree than the class II genes. We have previously shown that allele 3 of microsatellite marker D6S2223, 4.9 Mb telomeric of DQ in the extended class I region, is associated with a reduction in risk conferred by the DQ2-DR3 haplotype. Here we replicate this finding in two populations from Sweden and France. We also show that markers in the HLA class II, III and centromeric class I regions contribute to the DQ2-DR3 associated risk of T1D, independently of linkage disequilibrium (LD) with both the DQ/DR genes and the D6S2223 associated gene. The associated marker alleles are carried on the DQ2-DR3-B18 haplotype in a region of strong LD. By haplotype mapping, we have located the most likely location for this second DQ2-DR3 haplotype-modifying locus to the 2.35 Mb region between HLA-DOB and marker D6S2702, located 970 kb telomeric of HLA-B.
对1型糖尿病(T1D)的易感性以及对其发病的保护作用主要与HLA II类基因(DQB1、DQA1和DRB1)高度多态的外显子2序列相关。然而,多项研究也表明,HLA复合体中的其他基因也会影响T1D风险,尽管其影响程度小于II类基因。我们之前已经表明,位于扩展I类区域中DQ端粒4.9 Mb处的微卫星标记D6S2223的等位基因3与DQ2 - DR3单倍型所赋予的风险降低有关。在此,我们在来自瑞典和法国的两个人群中重复了这一发现。我们还表明,HLA II类、III类和着丝粒I类区域中的标记物对DQ2 - DR3相关的T1D风险有贡献,这与它们与DQ/DR基因以及与D6S2223相关基因的连锁不平衡(LD)无关。相关的标记等位基因在强LD区域的DQ2 - DR3 - B18单倍型上携带。通过单倍型定位,我们已经将这个第二个DQ2 - DR3单倍型修饰位点最可能的位置定位到HLA - DOB和标记物D6S2702之间的2.35 Mb区域,该标记物位于HLA - B端粒970 kb处。